ArticleClinicoEconomics and outcomes research : CEOR2015

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir.

David R Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.